Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Koeken, Valerie A C MIssue Date
2021-08-04
Metadata
Show full item recordAbstract
The tuberculosis vaccine BCG may protect against inflammation in the elderly as well as offer an option for protection from SARS-CoV-2 in developing countries.Citation
Sci Adv. 2021 Aug 4;7(32):eabk1668. doi: 10.1126/sciadv.abk1668. PMID: 34348906.Affiliation
CiiM, Zentrum für individualisierte Infektionsmedizin, Feodor-Lynen-Str.7, 30625 Hannover.Publisher
AAASJournal
Science advancesPubMed ID
34348906Type
ArticleLanguage
enEISSN
2375-2548ae974a485f413a2113503eed53cd6c53
10.1126/sciadv.abk1668
Scopus Count
The following license files are associated with this item:
- Creative Commons
Related articles
- Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
- Authors: Covián C, Retamal-Díaz A, Bueno SM, Kalergis AM
- Issue date: 2020
- BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check.
- Authors: Pandita A, Bhat A, Koul A, Singh SK
- Issue date: 2021
- Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany.
- Authors: Marín-Hernández D, Nixon DF, Hupert N
- Issue date: 2021 Aug 3
- New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
- Authors: Gupta PK
- Issue date: 2020 Oct
- Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
- Authors: Alyasin S, Kanannejad Z, Esmaeilzadeh H, Nabavizadeh H, Ghatee MA, Amin R
- Issue date: 2021 Feb 11